Pavella Therapeutics Inc. Insider Trading

PVLA

Last 12 months

Insiders bought 850K and sold $13.8M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. Director Christopher P Kiritsy sold 49K on Sep 2, 56% of their stake, outside a plan.

Net open-market

−$13M

3 buys · 15 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

2 / 3

executives and directors

Last open-market buy

Mar 2026

Mar 30, 2026

Get an email when PVLA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 21	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 3 parts	4,313	$124.58 average	537K	100%	Form 4
Oct 12 – 14	George M Jenkins Director	Sold10b5-1 plan 17 parts	27,500	$130.16 average	$3.58M	16%	Form 4
Sep 16	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 3 parts	4,302	$152.24 average	655K	100%	Form 4
Sep 11 – 15	George M Jenkins Director	Sold10b5-1 plan 9 parts	27,500	$151.53 average	$4.17M	14%	Form 4
Sep 2	Christopher P Kiritsy Director	SoldNo plan	313	$157.00	49K	56%	Form 4
Aug 19	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 5 parts	4,302	$152.21 average	655K	100%	Form 4
Jul 15	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 4 parts	4,302	$149.28 average	642K	100%	Form 4
Jun 17	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 3 parts	4,302	$110.73 average	476K	100%	Form 4
May 20	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 3 parts	4,302	$110.56 average	476K	100%	Form 4
Apr 15	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 5 parts	4,302	$127.24 average	547K	100%	Form 4
Mar 30	George M Jenkins Director	Bought	445	$112.30	50K	0.2%	Form 4
Mar 18	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 3 parts	4,302	$117.99 average	508K	100%	Form 4
Feb 27	George M Jenkins Director	Bought	4,000	$125.00	500K	2.0%	Form 4
Feb 27	Elaine J Heron Director	Bought	2,400	$125.00	300K	4.7%	Form 4
Feb 18	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 2 parts	4,302	$79.40 average	342K	100%	Form 4
Jan 21	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 2 parts	4,302	$97.63 average	420K	100%	Form 4
Dec 17, 2025	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan	4,302	$96.47	415K	100%	Form 4
Nov 19, 2025	Kathleen Goin Chief Operating Officer	Sold10b5-1 plan 2 parts	4,302	$86.23 average	371K	100%	Form 4
Apr 9, 2025	George M Jenkins Director	Bought 2 parts	4,990	$20.20 average	101K	2.6%	Form 4
Dec 18, 2024	George M Jenkins Director	Bought	4,000	$12.93	52K	2.1%	Form 4

Oct 2110b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,313 at avg $124.58
537K
100% of stake
Oct 12 – 1410b5-1 plan
George M Jenkins
Director · sold 27,500 at avg $130.16
$3.58M
16% of stake
Sep 1610b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $152.24
655K
100% of stake
Sep 11 – 1510b5-1 plan
George M Jenkins
Director · sold 27,500 at avg $151.53
$4.17M
14% of stake
Sep 2No plan
Christopher P Kiritsy
Director · sold 313 at $157.00
49K
56% of stake
Aug 1910b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $152.21
655K
100% of stake
Jul 1510b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $149.28
642K
100% of stake
Jun 1710b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $110.73
476K
100% of stake
May 2010b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $110.56
476K
100% of stake
Apr 1510b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $127.24
547K
100% of stake
Mar 30
George M Jenkins
Director · bought 445 at $112.30
50K
0.2% of stake
Mar 1810b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $117.99
508K
100% of stake
Feb 27
George M Jenkins
Director · bought 4,000 at $125.00
500K
2.0% of stake
Feb 27
Elaine J Heron
Director · bought 2,400 at $125.00
300K
4.7% of stake
Feb 1810b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $79.40
342K
100% of stake
Jan 2110b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $97.63
420K
100% of stake
Dec 17, 202510b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at $96.47
415K
100% of stake
Nov 19, 202510b5-1 plan
Kathleen Goin
Chief Operating Officer · sold 4,302 at avg $86.23
371K
100% of stake
Apr 9, 2025
George M Jenkins
Director · bought 4,990 at avg $20.20
101K
2.6% of stake
Dec 18, 2024
George M Jenkins
Director · bought 4,000 at $12.93
52K
2.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PVLA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PVLA

CompareIntrinsic value

ARWRArrowhead Pharmaceuticals Inc.

$61.65+3.56%40

TVTXTravere Therapeutics Inc.

$52.64+6.54%52

RIGLRigel Pharmaceuticals, Inc.

$51.29+4.97%87

SNDXSyndax Pharmaceuticals Inc.

$10.45-26.87%0

INDVIndivior Pharmaceuticals, Inc.

$36.28+2.57%80

JAZZJazz Pharmaceuticals plc

$234.66+2.14%58

OCULOcular Therapeutix Inc.

$7.14+4.69%10

ABBVAbbVie Inc.

$294.83+3.09%49

Held by ETFs

PVLA is in 29 US ETFs. The largest of them, with PVLA's weight in each:

Spot a number that looks wrong? Check it in PVLA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PVLA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.